We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$571M
AUM Growth
+$64.7M
(+13%)
Cap. Flow
+$77M
Cap. Flow
% of AUM
13.5%
Top 10 Holdings %
Top 10 Hldgs %
32.92%
Holding
757
New
120
Increased
159
Reduced
207
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$35.4M |
| 2 |
Stellantis
STLA
|
+$22.2M |
| 3 |
PepsiCo
PEP
|
+$18M |
| 4 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$6.64M |
| 5 |
Kohl's
KSS
|
+$5.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$21.5M |
| 2 |
iShares MSCI Indonesia ETF
EIDO
|
+$11.1M |
| 3 |
Eaton
ETN
|
+$4.76M |
| 4 |
Delta Air Lines
DAL
|
+$4.4M |
| 5 |
Western Union
WU
|
+$4.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.66% |
| 2 | Consumer Discretionary | 12.98% |
| 3 | Consumer Staples | 8.41% |
| 4 | Energy | 8.01% |
| 5 | Industrials | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
SS&C Technologies
SSNC
$18.9B
| $741K | 0.13% |
12,864
-4,295
| -25% | -$259K |
|
127
Trane Technologies
TT
$98.8B
| $739K | 0.13% |
5,839
+5,828
| +52,982% | +$697K |
|
128
Global Payments
GPN
$24.1B
| $737K | 0.13% |
4,606
+4,593
| +35,331% | +$683K |
|
129
Broadridge
BR
$18.4B
| $731K | 0.13% |
+5,731
| New | +$690K |
|
130
CVS Health
CVS
$135B
| $727K | 0.13% |
13,347
+10,303
| +338% | +$555K |
|
|
CRON
131
Cronos Group
CRON
$1.07B
| $724K | 0.13% |
45,303
+18,379
| +68% | +$297K |
|
132
Franco-Nevada
FNV
$41.3B
| $723K | 0.13% |
8,515
-11,999
| -58% | -$906K |
|
|
APHA
133
DELISTED
Aphria Inc. Common Shares
APHA
| $723K | 0.13% |
103,130
+79,350
| +334% | +$600K |
|
|
134
CALL
UBS Group
UBS
$170B
| $722K | 0.13% |
42,015
-2,336
| -5% | -$28.6K |
|
135
Southern Company
SO
$108B
| $700K | 0.12% |
12,668
-42,091
| -77% | -$2.25M |
|
136
T-Mobile US
TMUS
$195B
| $683K | 0.12% |
9,222
+9,197
| +36,788% | +$683K |
|
137
Wells Fargo
WFC
$254B
| $671K | 0.12% |
14,187
+5,450
| +62% | +$255K |
|
138
Salesforce
CRM
$154B
| $660K | 0.12% |
4,353
+3,619
| +493% | +$567K |
|
139
Baidu
BIDU
$35.7B
| $658K | 0.12% |
+5,606
| New | +$798K |
|
|
CTRA
140
DELISTED
Coterra Energy
CTRA
| $658K | 0.12% |
28,653
-12,234
| -30% | -$311K |
|
141
Vale
VALE
$62.3B
| $647K | 0.11% |
48,134
+17,203
| +56% | +$221K |
|
142
Archer Daniels Midland
ADM
$38.7B
| $645K | 0.11% |
+15,808
| New | +$655K |
|
143
Kinross Gold
KGC
$27.7B
| $640K | 0.11% |
164,896
+120,013
| +267% | +$404K |
|
144
Thermo Fisher Scientific
TMO
$214B
| $635K | 0.11% |
2,164
+1,817
| +524% | +$500K |
|
|
CGC
145
Canopy Growth
CGC
$376M
| $635K | 0.11% |
1,575
+244
| +18% | +$107K |
|
146
Vipshop
VIPS
$7.26B
| $631K | 0.11% |
73,197
-238,684
| -77% | -$1.92M |
|
147
TC Energy
TRP
$70.1B
| $631K | 0.11% |
12,718
+4,700
| +59% | +$225K |
|
148
PUT
TechnipFMC
FTI
$28.6B
| $624K | 0.11% |
4,428
-632
| -12% | -$11.1K |
|
|
BITA
149
DELISTED
Bitauto Holdings Limited
BITA
| $616K | 0.11% |
+58,867
| New | +$712K |
|
150
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $610K | 0.11% |
+7,000
| New | +$604K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2019 Portfolio in Review
As of Q2 2019, Exane Derivatives held 757 positions worth $571M, up 13% from $506M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Exane Derivatives deployed $77M of net new capital in Q2 2019, opening 120 new positions and adding to 159 existing holdings. Its largest new stake was Stellantis: 1,528,258 shares worth $21.6M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 7.7% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was iShares MSCI Indonesia ETF, an estimated $11.1M trimmed.
- Exane Derivatives's largest Q2 2019 buy was Stellantis: 1,528,258 shares worth $21.6M.
- Exane Derivatives added most to UBS Group in Q2 2019, an estimated $35.4M increase.
- Exane Derivatives's biggest Q2 2019 reduction was iShares MSCI Indonesia ETF, cutting an estimated $11.1M.
- Exane Derivatives fully exited Linde in Q2 2019, selling an estimated $21.5M.
- Exane Derivatives's ten largest holdings make up 33% of its $571M portfolio in Q2 2019.
- Exane Derivatives opened 120 new positions and closed 89 in Q2 2019.
- Exane Derivatives's portfolio value rose 13% quarter-over-quarter to $571M.
Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.